Shares of Xometry, Inc. (NASDAQ:XMTR - Get Free Report) have earned an average rating of "Moderate Buy" from the thirteen ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $113.18.
A number of equities research analysts have weighed in on XMTR shares. UBS Group boosted their price objective on Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Rosenblatt Securities lifted their target price on shares of Xometry from $110.00 to $120.00 and gave the company a "buy" rating in a report on Tuesday, September 22nd. Royal Bank Of Canada upped their price target on shares of Xometry from $85.00 to $100.00 and gave the company a "sector perform" rating in a research report on Wednesday, August 5th. Citigroup reiterated a "market outperform" rating on shares of Xometry in a research note on Monday, September 21st. Finally, Cantor Fitzgerald raised their price objective on shares of Xometry from $85.00 to $110.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 5th.
View Our Latest Report on XMTR
Xometry Stock Performance
Shares of XMTR stock opened at $104.23 on Friday. The stock's 50-day moving average is $91.70 and its two-hundred day moving average is $79.11. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21. Xometry has a 1 year low of $35.86 and a 1 year high of $107.93. The firm has a market cap of $5.40 billion, a price-to-earnings ratio of -173.71 and a beta of 1.23.
Xometry (NASDAQ:XMTR - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.01. The business had revenue of $229.28 million during the quarter, compared to the consensus estimate of $215.22 million. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%.The business's quarterly revenue was up 41.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.09 EPS. Analysts predict that Xometry will post -0.01 earnings per share for the current year.
Insider Buying and Selling at Xometry
In other Xometry news, Director Emily Rollins sold 5,000 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $84.31, for a total transaction of $421,550.00. Following the completion of the sale, the director directly owned 15,136 shares of the company's stock, valued at $1,276,116.16. This represents a 24.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sanjeev Sahni sold 1,500 shares of the stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $85.23, for a total value of $127,845.00. Following the sale, the chief executive officer directly owned 180,903 shares of the company's stock, valued at $15,418,362.69. The trade was a 0.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 44,500 shares of company stock valued at $4,067,473. Corporate insiders own 9.10% of the company's stock.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of XMTR. Wellington Management Group LLP lifted its holdings in shares of Xometry by 26.9% during the second quarter. Wellington Management Group LLP now owns 1,322,581 shares of the company's stock worth $127,656,000 after purchasing an additional 280,491 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Xometry by 243.6% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 694,390 shares of the company's stock valued at $29,015,000 after buying an additional 492,285 shares during the period. Sylebra Capital LLC increased its stake in Xometry by 31.3% in the 1st quarter. Sylebra Capital LLC now owns 535,624 shares of the company's stock valued at $21,875,000 after buying an additional 127,637 shares during the period. BNP Paribas Financial Markets raised its position in Xometry by 1,121.8% during the 4th quarter. BNP Paribas Financial Markets now owns 207,682 shares of the company's stock worth $12,351,000 after buying an additional 190,684 shares during the last quarter. Finally, Capital International Investors purchased a new position in Xometry during the 4th quarter worth $11,949,000. Institutional investors and hedge funds own 97.31% of the company's stock.
Xometry Company Profile
(
Get Free Report)
Xometry, Inc is a digital manufacturing marketplace that connects businesses with a network of manufacturing suppliers. Its platform uses software and artificial intelligence to help customers obtain quotes, place orders, and manage production for custom parts and components.
The company supports a range of manufacturing processes, including computer numerical control machining, 3D printing, sheet metal fabrication, injection molding, and related services. Xometry serves customers across industries such as aerospace and defense, automotive, industrial machinery, consumer products, and healthcare.
Founded in 2013, Xometry has expanded its marketplace and digital manufacturing services internationally, serving customers and suppliers in North America, Europe, and Asia.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.